RxDoctor Payments Data

Delia Herzog, MD

Family Medicine · Marysville, OHNPI 1285684282

Payments from drug & device makers

$6,162in general payments, 2019–2025

Across 410 payments — averaging $15.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$861
  • Lilly USA, LLC$624
  • Johnson & Johnson$603
  • Amgen$585
  • Novo Nordisk$428
  • Pfizer$426
  • plus $3K from 35 others

What the payments were for

  • Food & beverage$6,143100%
  • Education$200%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,162 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$38,548
Medicare patients
190
Services billed
1,030

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide68$91,627
EliquisApixaban67$55,824
JardianceEmpagliflozin53$54,278
RybelsusSemaglutide38$46,896
OzempicSemaglutide31$41,692
XifaxanRifaximin12$35,675
FarxigaDapagliflozin Propanediol35$33,725
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$27,606
TrulicityDulaglutide20$23,944
AbrysvoRsv Vacc, Pref A And Pref B/Pf61$19,215
Repatha SureclickEvolocumab24$17,623
MyrbetriqMirabegron12$16,222
Tresiba Flextouch U-200Insulin Degludec15$14,529
OxycontinOxycodone Hcl11$13,201
Breo ElliptaFluticasone/Vilanterol20$12,015

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$624$115,57188 claims
Novo NordiskRybelsus, Ozempic$428$88,58869 claims
PfizerEliquis, Abrysvo$426$75,039128 claims
Boehringer IngelheimJardiance$229$54,27853 claims
GSKTrelegy Ellipta, Breo Ellipta, Shingrix, Anoro Ellipta$375$52,22092 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$161$35,67512 claims
AstraZenecaFarxiga$359$33,72535 claims
Astellas Pharma US IncMyrbetriq$136$16,22212 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$36$3,462222 claims
AbbVieSynthroid$861$2,25242 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Marysville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →